259 related articles for article (PubMed ID: 25252739)
1. Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.
Reddy AT; Lakshmi SP; Zhang Y; Reddy RC
FASEB J; 2014 Dec; 28(12):5299-310. PubMed ID: 25252739
[TBL] [Abstract][Full Text] [Related]
2. Nitrated Fatty Acids Reverse Cigarette Smoke-Induced Alveolar Macrophage Activation and Inhibit Protease Activity via Electrophilic S-Alkylation.
Reddy AT; Lakshmi SP; Muchumarri RR; Reddy RC
PLoS One; 2016; 11(4):e0153336. PubMed ID: 27119365
[TBL] [Abstract][Full Text] [Related]
3. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
Tumelty KE; Smith BD; Nugent MA; Layne MD
J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
5. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
[TBL] [Abstract][Full Text] [Related]
6. A novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung.
Matsuhira T; Nishiyama O; Tabata Y; Kaji C; Kubota-Ishida N; Chiba Y; Sano H; Iwanaga T; Tohda Y
Eur J Pharmacol; 2020 Oct; 885():173508. PubMed ID: 32858049
[TBL] [Abstract][Full Text] [Related]
7. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.
Smith MR; Gangireddy SR; Narala VR; Hogaboam CM; Standiford TJ; Christensen PJ; Kondapi AK; Reddy RC
Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L616-25. PubMed ID: 20061443
[TBL] [Abstract][Full Text] [Related]
9. GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro.
Speca S; Dubuquoy C; Rousseaux C; Chavatte P; Desreumaux P; Spagnolo P
PLoS One; 2021; 16(9):e0257281. PubMed ID: 34529707
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
Uhal BD; Kim JK; Li X; Molina-Molina M
Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
[TBL] [Abstract][Full Text] [Related]
11. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
Milam JE; Keshamouni VG; Phan SH; Hu B; Gangireddy SR; Hogaboam CM; Standiford TJ; Thannickal VJ; Reddy RC
Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L891-901. PubMed ID: 18162602
[TBL] [Abstract][Full Text] [Related]
12. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
[TBL] [Abstract][Full Text] [Related]
13. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis.
Artaud-Macari E; Goven D; Brayer S; Hamimi A; Besnard V; Marchal-Somme J; Ali ZE; Crestani B; Kerdine-Römer S; Boutten A; Bonay M
Antioxid Redox Signal; 2013 Jan; 18(1):66-79. PubMed ID: 22703534
[TBL] [Abstract][Full Text] [Related]
15. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
16. PPARγ mediates the anti-pulmonary fibrosis effect of icaritin.
Hua Q; Huang X; Xie W; Zhao F; Cheng H; Luo Z; Han J; Wang Z; Zeng Q; Lin M; Zhou T; Zhang J; Gu C; Liu W; Tang S
Toxicol Lett; 2021 Oct; 350():81-90. PubMed ID: 34153405
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.
Kapoun AM; Gaspar NJ; Wang Y; Damm D; Liu YW; O'young G; Quon D; Lam A; Munson K; Tran TT; Ma JY; Murphy A; Dugar S; Chakravarty S; Protter AA; Wen FQ; Liu X; Rennard SI; Higgins LS
Mol Pharmacol; 2006 Aug; 70(2):518-31. PubMed ID: 16707625
[TBL] [Abstract][Full Text] [Related]
18. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
19. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.
Kurowska-Stolarska M; Hasoo MK; Welsh DJ; Stewart L; McIntyre D; Morton BE; Johnstone S; Miller AM; Asquith DL; Millar NL; Millar AB; Feghali-Bostwick CA; Hirani N; Crick PJ; Wang Y; Griffiths WJ; McInnes IB; McSharry C
J Allergy Clin Immunol; 2017 Jun; 139(6):1946-1956. PubMed ID: 27746237
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
